{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:54:39Z","timestamp":1773338079606,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.1953","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T22:04:07Z","timestamp":1434319447000},"page":"1489-1498","source":"Crossref","is-referenced-by-count":15,"title":["Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012)"],"prefix":"10.2169","volume":"54","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tahara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Nagahiro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kuranaga Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Koketsu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Toyofuku","sequence":"additional","affiliation":[{"name":"Department of Surgery, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Beppu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Himeji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Yokota-Ikeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanshiro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenobu","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Trauma and Critical Care Center, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Devision of Gastroenterology and Hematology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492, 1977."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81: 2534-2537, 1984.","DOI":"10.1073\/pnas.81.8.2534"},{"key":"3","unstructured":"3. Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 15: 423-430, 1985."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79: 428-437, 1991.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takasaki Y, Iwanaga M, Imaizumi Y, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 115: 4337-4343, 2010.","DOI":"10.1182\/blood-2009-09-242347"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113: 375-382, 2001.","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25: 5458-5464, 2007.","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia\/lymphoma: past, present, and future. Eur J Haematol 80: 185-196, 2008.","DOI":"10.1111\/j.1600-0609.2007.01016.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol 27: 453-459, 2009.","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hematop 50: 9-25, 2010.","DOI":"10.3960\/jslrt.50.9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tsukasaki K, Tobinai K. Clinical trials and treatment of ATL. Leuk Res Treatment 2012: 101754, 2012.","DOI":"10.1155\/2012\/101754"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. Leukemia 19: 829-834, 2005.","DOI":"10.1038\/sj.leu.2403682"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood 105: 4143-4145, 2005.","DOI":"10.1182\/blood-2004-11-4193"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tanosaki R, Uike N, Utsunomiya A, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant 14: 702-708, 2008.","DOI":"10.1016\/j.bbmt.2008.03.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116: 1369-1376, 2010.","DOI":"10.1182\/blood-2009-10-247510"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ishida T, Hishizawa M, Kato K, et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120: 1734-1741, 2012.","DOI":"10.1182\/blood-2012-03-414490"},{"key":"17","unstructured":"17. Yamada Y, Atogami S, Hasegawa H, et al. Nationwide survey of adult T-cell leukemia\/lymphoma (ATL) in Japan. Rinsho Ketsueki (Japanese Journal of Clinical Hematology) 52: 1765-1771, 2011 (in Japanese, Abstract in English)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Taguchi H, Kinoshita KI, Takatsuki K, et al. An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 12: 182-186, 1996.","DOI":"10.1097\/00042560-199606010-00012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Itoh K, Ohtsu T, Fukuda H, et al; Members of the lymphoma study group of the Japan Clinical Oncology Group (JCOG). Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol 13: 1347-1355, 2002.","DOI":"10.1093\/annonc\/mdf287"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nagafuji K, Miyamoto T, Eto T, et al. Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study). J Hematol Oncol 6: 14, 2013.","DOI":"10.1186\/1756-8722-6-14"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ogura M, Kagami Y, Taji H, et al. Pilot phase I\/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma. Int J Hematol 77: 503-511, 2003.","DOI":"10.1007\/BF02986620"},{"key":"22","unstructured":"22. Okamoto M, Maruyama F, Tsuzuki M, et al. Salvage chemotherapy for relapsed\/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin. Rinsho Ketsueki (Japanese Journal of Clinical Hematology) 35: 635-641, 1944 (in Japanese, Abstract in English)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ref Valasquez W, McLaughlin P, Tucker S, et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12: 1169-1176, 1944.","DOI":"10.1200\/JCO.1994.12.6.1169"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30: 837-842, 2012.","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Katsuya H, Yamanaka T, Ishitsuka K, et al. Prognostic index for acute and lymphoma type adult T-cell leukemia\/lymphoma. J Clin Oncol 30: 1635-1640, 2012.","DOI":"10.1200\/JCO.2011.38.2101"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kannagi M. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia. Int J Hematol 86: 113-117, 2007.","DOI":"10.1532\/IJH97.07092"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tanaka Y, Nakasone H, Yamazaki R, et al. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia\/lymphoma after allogeneic stem cell transplantation. J Clin Immunol 32: 1340-1352, 2012.","DOI":"10.1007\/s10875-012-9729-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jo T, Ishida T, Takemoto S, et al. Randomoized phase II study of mogamulizumab (KW-0761) plus mLSG 15 versus mLSG 15 alone for newly diagnosed aggressive ATL. J Clin Oncol 31: 8506, 2013.","DOI":"10.1200\/jco.2013.31.15_suppl.8506"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ishida T. New therapeutic strategy for adult T-cell leukemia. Nihon Naika Gakkai Zasshi (Journal of the Japanese Society of Internal Medicine) 102: 1744-1750, 2013 (in Japanese).","DOI":"10.2169\/naika.102.1744"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ito Y, Miyamoto T, Chong Y, et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia\/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 48: 998-999, 2013.","DOI":"10.1038\/bmt.2012.268"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:02:14Z","timestamp":1599134534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/12\/54_54.1953\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.1953","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}